HeartSine® was founded in 1997 for the purpose of developing a family of products focused on an emerging growth segment of the medical device marketplace: easy-to-use, affordable defibrillators for the home and public access markets. HeartSine® established R&D activities in Northern Ireland and initiated a formal collaboration with the University of Ulster’s Bioengineering Center (NIBEC) and its partner, the Royal Victoria Hospital (RVH), a local teaching and research hospital, to augment and enhance our in-house development activities. HeartSine’s engineering team has focused on developing leading edge, innovative technology systems for defibrillators.

HeartSine’s technology and innovation is based on a proven history of development in the field of cardiac defibrillation that began in the 1960s.